Centiva Capital’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
SCM
FIS
VCM
Centiva Capital's REPL Position: Q1 2026 in Review
Centiva Capital held its Replimune Group (REPL) position steady in Q1 2026 at 18,000 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1345.
Centiva Capital first reported a position in REPL in Q2 2024 and has held it in 4 quarters since. The position peaked at $690K in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.
- Centiva Capital held 18,000 shares of Replimune Group worth $138K as of Q1 2026.
- Centiva Capital left its Replimune Group share count unchanged in Q1 2026.
- Replimune Group made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1345 holding.
- Centiva Capital first reported a position in Replimune Group in Q2 2024 and has held it in 4 quarters since.
- Centiva Capital's Replimune Group position peaked at $690K in Q2 2025.
- 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.
Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.